tiprankstipranks
Trending News
More News >

Johnson & Johnson Insider Profile

46 Followers
Johnson & Johnson, Ten Percent Owner at Achillion Pharmaceuticals, holds 4.05M shares in CVRx (Ticker: CVRX), holds 182.33M shares in Kenvue, Inc. (Ticker: KVUE), holds 3.67M shares in Fusion Pharmaceuticals (Ticker: FUSN). Most recently, Johnson & Johnson Sold ― shares of CVRx on Nov 25, 2025 for an estimated value of $27.13K.
tipranks
Johnson & Johnson

Johnson & Johnson
Achillion Pharmaceuticals (~ACHN)
Ten Percent Owner

Ranked #85,228 out of 104,449 Corporate Insiders

Profitable Transactions

37%
7 out of 19 Profitable Transactions

Average Return

-11.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3B
97.82%
1.27%
0.54%
0.29%
0.07% Others
A breakdown of Johnson & Johnson's holdings

Insider Roles

Kenvue, Inc.
(KVUE)
Ten Percent Owner
CVRx
(CVRX)
Ten Percent Owner
Minerva Neurosciences
(NERV)
Ten Percent Owner
Aldeyra Therapeutics
(ALDX)
Ten Percent Owner
+4 other positions
Roles that Johnson & Johnson holds in companies

Most Profitable Insider Trade

Stock:
Nevro Corp
(NVRO)
Rating:Informative Buy
Date:Nov 12, 2014 - Nov 12, 2015
Return:+89.00%
The most profitable trade made by Johnson & Johnson

Johnson & Johnson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ACHN
Achillion Pharmaceuticals
Nov 22, 2017
Informative Sell
50.51M
$0.00
FUSN
Fusion Pharmaceuticals
Jul 02, 2020
Uninformative Buy
$79.10M
CVRx
Nov 25, 2025
Ten Percent Owner
Informative Sell
27.13K
$39.82M
Kenvue, Inc.
Aug 25, 2023
Ten Percent Owner
Uninformative Sell
$3.06B
Tengion
Apr 14, 2010
Ten Percent Owner
Informative Buy
2.00M
NVRO
Nevro Corp
Jun 08, 2015
Informative Sell
48.43M
$12.07M
Minerva Neurosciences
Sep 14, 2017
Ten Percent Owner
Uninformative Sell
$17.01M
Neurogene
Aug 12, 2015
Ten Percent Owner
Informative Sell
33.94M
$2.04M
Genocea Biosciences
Ten Percent Owner
Aldeyra Therapeutics
May 02, 2014
Ten Percent Owner
Informative Buy
375.08K
$9.15M
~CRTX
Cornerstone Therapeutics Inc
Opko Health
Ten Percent Owner
$0.00
List of latest transactions for each holding click on a transaction to see Johnson & Johnson's performance on stock

Johnson & Johnson insider profile FAQ

What is the percentage of profitable transactions made by Johnson & Johnson?
The percentage of profitable transactions made by Johnson & Johnson is 37%.
    What is the average return per transaction made by Johnson & Johnson?
    The average return per transaction made by Johnson & Johnson is -11.00%.
      What stocks does Johnson & Johnson hold?
      Johnson & Johnson holds: ~ACHN, FUSN, CVRX, KVUE, TNGNQ, NVRO, NERV, NGNE, GNCAQ, ALDX, ~CRTX, OPK stocks.
        What was Johnson & Johnson’s latest transaction?
        Johnson & Johnson latest transaction was an Informative Sell of $27.13K.
          What was Johnson & Johnson's most profitable transaction?
          Johnson & Johnson’s most profitable transaction was an Informative Buy of NVRO stock on November 12, 2014. The return on the trade was 89.00%.
            What is Johnson & Johnson's role in Achillion Pharmaceuticals?
            Johnson & Johnson's role in Achillion Pharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.